A. Paul Kelly, Md Research Award And Lectureship Grant

The A. Paul Kelly, MD Research Award and Lectureship honors the legacy of Dr. A. Paul Kelly, a pioneer in dermatological research focusing on skin diseases in people of color. Established in 2021, this award recognizes dermatologists committed to advancing the understanding and treatment of skin conditions in underserved populations. The awardee will receive a $10,000 cash prize and present a 30-minute lecture at the summer Innovation Academy’s Plenary session.

About Dr.Kelly
The award is named for Dr. A. Paul Kelly, who throughout his career researched skin diseases in people of color, particularly keloidal scarring. After retirement, he became a Fulbright Regional Research Scholar and brought his keloid research project to Sultan Qaboos University in Oman, where he assembled an extraordinary international team of dermatologists and geneticists to carry out an ongoing epidemiological and genetic study on familial keloids. Dr. Kelly inspired and challenged nearly 90 dermatology residents, countless medical students, and numerous dermatology colleagues, domestically and globally, to address critical issues in dermatology and medicine.
Honoring a leader
Throughout his career, Dr. A. Paul Kelly researched skin diseases in people of color, particularly keloidal scarring.
The A. Paul Kelly, MD Research Award and Lectureship was created in 2021 to recognize outstanding dermatologists who, throughout their career, have been committed to researching issues associated with skin of color and improving dermatological care for patients.
The selected lecturer will receive a cash award of $10,000 and present a lecture of approximately 30 minutes at the summer Innovation Academy’s Plenary session.

Eligibility

The recipient selected may be a physician or non-physician of national or international stature.The recipient should be a recognized expert whose contributions to the understanding of skin diseases in people of color and/or underserved patient populations have been outstanding in innovation and practice.The recipient should still be actively engaged in clinically important research and investigation.The recipient should have proven ability as a communicator, both verbal and written